Bioxytran, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | 275.1% | 275.1% | — |
| FY2010 | 600.6% | 600.6% | -416.8% |
| FY2011 | -2,714.6% | -2,714.6% | -2,051.1% |
| FY2012 | -647.7% | -647.7% | -535.3% |
| FY2013 | -2,357.3% | -2,357.3% | -688.2% |
| FY2014 | 608.2% | 608.2% | -1,189.0% |
| FY2015 | 1,075.8% | 1,075.8% | -3,762.6% |
| FY2016 | 239.8% | 239.8% | -1,348.4% |
| FY2017 | 24,322.9% | 24,322.9% | -289,442.7% |
| FY2018 | 131.6% | 131.6% | -814.1% |
| FY2019 | 232.5% | 232.5% | -846.2% |
| FY2020 | 131.0% | 131.0% | -779.0% |
| FY2021 | 127.7% | 127.7% | -3,379.8% |
| FY2022 | 75.0% | 75.0% | -666.7% |
| FY2023 | 144.0% | 144.0% | -3,208.8% |
| FY2024 | 132.1% | 132.1% | -1,706.4% |
| FY2025 | 81.9% | 81.9% | -322.4% |